Breast cancer diagnosed during hormone replacement therapy

Obstetrics and Gynecology

Volumn 95, Issue 4, 2000, Pages 513-518

  Gajdos, Csaba ^a   Tartter, Paul Ian ^a   Babinszki, Agota ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INVASION; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; MEDICAL RECORD; META ANALYSIS; NEEDLE BIOPSY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RADIOTHERAPY; RECEPTOR DENSITY; SURGICAL TECHNIQUE; TUMOR VOLUME;

AGED; BODY MASS INDEX; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED;

EID: 0034050242     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00594-3     Document Type: Article

References (15)

1. Breast cancer and hormone replacement therapy Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer . Lancet. 350:1997;1047-1059.
2. Schairer C., Adami H.O., Hoover R., Persson I. Cause-specific mortality in women receiving hormone replacement therapy. Epidemiology. 8:1997;59-65.
3. Willis D.B., Calle E.E., Miracle-McMahill H.L., Heath C.W. Jr. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control. 7:1996;449-457.
4. Bergkvist L., Adami H.O., Persson I., Bergstrom R., Krusemo U.B. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progesterone replacement therapy. Am J Epidemiol. 130:1989;221-228.
5. Strickland D.M., Gambrell R.D. Jr, Butzin C.A., Strickland K. The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynecol. 80:1992;400-404.
6. Bonnier P., Romain S., Giacalone P.L., Laffargue F., Martin P.M., Piana L. Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol. 85:1995;11-17.
7. Squitieri R., Tartter P.I., Ahmed S., Brower S.T., Thiese N.D. Carcinoma of the breast in postmenopausal hormone users and nonusers control groups. J Am Coll Surg. 178:1994;167-170.
8. Brinton L.A., Hoover R., Fraumeni J.F. Menopausal estrogens and breast cancer risk An expanded case-control study . Br J Cancer. 54:1986;825-832.
9. Potter J.D., Cerhan J.R., Sellers T.A., McGovern P.G., Drinkard C., Kushi L.R., et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study How many different kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev. 4:1995;319-326.
10. Cutler S.J., Ederer F.J. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 8:1958;699-718.
11. Breslow N. A generalized Kruskal-Wallis test for comparing k samples subject to unequal patterns of censorship. Biometrika. 57:1970;579-594.
12. Bilimoria M.M., Winchester D.J., Sener S.F., Motykie G., Sehgal U.L., Winchester D.P. Estrogen replacement therapy and breast cancer Analysis of age of onset and tumor characteristics . Ann Surg Oncol. 6:1999;200-207.
13. Paganini-Hill A. The risks and benefits of estrogen replacement therapy Leisure world . Int J Fertil. 40:1995;54-62.
14. Weiss S.E., Tartter P.I., Ahmed S., Brower S.T., Brusco C., Bossolt K., et al. Ethnic differences in risk and prognostic factors for breast cancer. Cancer. 76:1995;268-274.
15. Magnusson C., Holmberg L., Norden T., Lindgren A., Persson I. Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat. 38:1996;325-334.